Horizon Therapeutics Public Ltd Co

NORTHERN TRUST CORP

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/13/2023

Shares

1,604,037

Value ($000)

185,571

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/13/2023	185,571	0.0%	1,604,037	9/30/2023
2023 Q2	8/11/2023	154,620	0.0%	1,503,352	6/30/2023
2023 Q1	5/15/2023	166,151	0.0%	1,522,365	3/31/2023
2022 Q4	2/13/2023	178,418	0.0%	1,567,817	12/31/2022
2022 Q3	11/14/2022	98,833	0.0%	1,596,906	9/30/2022
2022 Q2	8/12/2022	127,103	0.0%	1,593,562	6/30/2022
2022 Q1	5/13/2022	167,826	0.0%	1,595,152	3/31/2022
2021 Q4	2/8/2022	180,159	0.0%	1,671,862	12/31/2021
2021 Q3	11/15/2021	182,792	0.0%	1,668,719	9/30/2021
2021 Q2	8/13/2021	144,539	0.0%	1,543,563	6/30/2021
2021 Q1	5/12/2021	122,948	0.0%	1,335,814	3/31/2021
2020 Q4	2/11/2021	96,522	0.0%	1,319,502	12/31/2020
2020 Q3	11/16/2020	78,540	0.0%	1,011,073	9/30/2020
2020 Q2	8/14/2020	54,438	0.0%	979,447	6/30/2020
2020 Q1	5/14/2020	28,234	0.0%	953,193	3/31/2020
2019 Q4	2/14/2020	32,531	0.0%	898,657	12/31/2019